BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4165540)

  • 1. [Studies on the life span of erythrocytes in hematologic and neoplastic diseases].
    Burger T; Keszthelyi B; Peer J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(1):39-49. PubMed ID: 4165540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of erythrocyte kinetics in hematologic disorders].
    Honetz N
    Wien Z Inn Med; 1972; 53(2):58-85. PubMed ID: 4504755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Life span of erythrocytes and sites of their destruction in hemolytic anemia].
    Sakhibov IaD; Aripov AIa
    Probl Gematol Pereliv Krovi; 1967 Dec; 12(12):16-20. PubMed ID: 5618029
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary excretion of 51 Cr from labeled erythrocytes. An index of erythrocyte survival.
    Shih SC; Tauxe WN; Fairbanks VF; Taswell HF
    JAMA; 1972 May; 220(6):814-7. PubMed ID: 5067347
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of splenectomy in hemolytic syndromes on the basis of clinical, hematologic and isotope indications.
    Rudowski W; Pawelski S; Konopka L; Kwietniak K; Zdiechowska H; Rechowicz K
    Pol Med J; 1968; 7(3):661-70. PubMed ID: 5669708
    [No Abstract]   [Full Text] [Related]  

  • 6. [Erythrocytes life span determined by means of Cr51 label, and its role in development of anemia in chronic lyeloid leukemia].
    Aripov AIa
    Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):12-7. PubMed ID: 5259264
    [No Abstract]   [Full Text] [Related]  

  • 7. Life-span and organ sequestration of the red cells in pyruvate kinase deficiency.
    Nathan DG; Oski FA; Miller DR; Gardner FH
    N Engl J Med; 1968 Jan; 278(2):73-81. PubMed ID: 5634483
    [No Abstract]   [Full Text] [Related]  

  • 8. [The evaluation of hemocatheresis by means of erythrocytes labeled with Cr51 as a test for selection of hemolytic anemia patients to undergo splenectomy].
    Spinelli Ressi F
    Haematol Lat; 1967; 10(4):381-90. PubMed ID: 5593507
    [No Abstract]   [Full Text] [Related]  

  • 9. [Erythrocyte life span and surface activity measurement with Cr 51 in hemolytic anemias: before and after treatment].
    Gehrmann G; Grobel P
    Nucl Med (Stuttg); 1963; 2():Suppl 1:217-23. PubMed ID: 5900115
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of Cr 51 in the assessment of the role of the spleen in red cell destruction.
    Hughes-Jones NC
    Nucl Med (Stuttg); 1963; 2():Suppl 1:185-93. PubMed ID: 5900111
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nuclear medical examinations as the basis of splenectomy in hemolytic anemia].
    Kammenhuber K; van de Berg A; Parade D
    Bruns Beitr Klin Chir (1971); 1969 Dec; 217(8):746-9. PubMed ID: 5386742
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial anemia in the Basenji dog.
    Tasker JB; Severin GA; Young S; Gillette EL
    J Am Vet Med Assoc; 1969 Jan; 154(2):158-65. PubMed ID: 5812576
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ultrastructure of erythroblasts in various hematological disorders (author's transl)].
    Miura AB; Shibata A; Akihama T; Endo Y; Saito Y
    Rinsho Ketsueki; 1974 Jul; 15(7):756-63. PubMed ID: 4610206
    [No Abstract]   [Full Text] [Related]  

  • 14. RELATION OF ALTERED PLASTICITY OF THE ERYTHROCYTES TO THEIR SHORTENED LIFE SPAN.
    TEITEL P
    Sangre (Barc); 1964; 41():421-6. PubMed ID: 14248829
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications for splenectomy in the anemic forms of myelofibrosis with myeloid metaplasia of the spleen].
    Dechavanne M; Viala JJ; Barbier Y; Revol L
    Sem Hop; 1972 Apr; 48(17):1187-92. PubMed ID: 4342370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kinetic study results with radiochromium-labeled erythrocytes in hemolytic anemia in childhood].
    Franke WG; Hennig K; Rönisch P; Woller P
    Radiobiol Radiother (Berl); 1969; 10(5):689-93. PubMed ID: 5362817
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythrocyte aging in infants determined by the Cr51 method].
    Urashima T
    Nihon Shonika Gakkai Zasshi; 1968 Dec; 72(12):1989-93. PubMed ID: 5752556
    [No Abstract]   [Full Text] [Related]  

  • 18. [RED BLOOD CELL HALF-LIFE IN HEMOLYTIC SYNDROMES STUDIED WITH RADIOACTIVE CHROMIUM (CR51)].
    MEZA C; CARRASCO V
    Rev Med Chil; 1964 Sep; 92():695-9. PubMed ID: 14242625
    [No Abstract]   [Full Text] [Related]  

  • 19. [HALF-LIFE OF RED BLOOD CELLS IN HEMOLYTIC SYNDROMES STUDIED WITH RADIOACTIVE CHROMIUM (CR 51)].
    MEZA-ARRAU C; CARRASCOREYES V
    Sangre (Barc); 1965; 10():155-62. PubMed ID: 14316022
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erythrocyte survival in hemolytic anemias].
    Neumann W; Siering H; Correns HJ; Unverricht A
    Z Gesamte Inn Med; 1969 Nov; 24(22):797-801. PubMed ID: 5368510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.